125 related articles for article (PubMed ID: 31690033)
21. Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors.
Yoon AR; Rivera-Cruz C; Gimble JM; Yun CO; Figueiredo ML
Mol Ther Oncolytics; 2022 Jun; 25():78-97. PubMed ID: 35434272
[TBL] [Abstract][Full Text] [Related]
22. Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy.
Dianat-Moghadam H; Mahari A; Salahlou R; Khalili M; Azizi M; Sadeghzadeh H
Stem Cell Res Ther; 2022 Apr; 13(1):150. PubMed ID: 35395787
[TBL] [Abstract][Full Text] [Related]
23. Emodin exerts antitumor effects in ovarian cancer cell lines by preventing the development of cancer stem cells via epithelial mesenchymal transition.
Long H; Chen H; Yan J; Cheng H
Oncol Lett; 2022 Mar; 23(3):95. PubMed ID: 35154426
[TBL] [Abstract][Full Text] [Related]
24. Targeting regulatory T cells for immunotherapy in melanoma.
Huang L; Guo Y; Liu S; Wang H; Zhu J; Ou L; Xu X
Mol Biomed; 2021; 2(1):11. PubMed ID: 34806028
[TBL] [Abstract][Full Text] [Related]
25. SNX-2112 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Non-Small Cell Lung Cancer by Downregulating Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Signaling Pathway.
Cheng X; Qin L; Deng L; Zhu X; Li Y; Wu X; Zheng Y
J Cancer; 2021; 12(19):5825-5837. PubMed ID: 34475996
[TBL] [Abstract][Full Text] [Related]
26. Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy.
Huppert LA; Green MD; Kim L; Chow C; Leyfman Y; Daud AI; Lee JC
Cell Mol Immunol; 2022 Jan; 19(1):33-45. PubMed ID: 34417572
[TBL] [Abstract][Full Text] [Related]
27. Hampering Stromal Cells in the Tumor Microenvironment as a Therapeutic Strategy to Destem Cancer Stem Cells.
Chung KPS; Leung RWH; Lee TKW
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202411
[TBL] [Abstract][Full Text] [Related]
28. Lycorine hydrochloride inhibits melanoma cell proliferation, migration and invasion via down-regulating p21
Shi S; Li C; Zhang Y; Deng C; Tan M; Pan G; Du J; Ji Y; Li Q; Liang H; Liu W; Guo L; Zhao G; Liu Y; Cui H
Am J Cancer Res; 2021; 11(4):1391-1409. PubMed ID: 33948364
[TBL] [Abstract][Full Text] [Related]
29. Smad7 suppresses melanoma lung metastasis by impairing Tregs migration to the tumor microenvironment.
Ma D; Qiao L; Guo B
Am J Transl Res; 2021; 13(2):719-731. PubMed ID: 33594321
[TBL] [Abstract][Full Text] [Related]
30. TGF-β in Cancer: Metabolic Driver of the Tolerogenic Crosstalk in the Tumor Microenvironment.
Angioni R; Sánchez-Rodríguez R; Viola A; Molon B
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33499083
[TBL] [Abstract][Full Text] [Related]
31. Transforming Growth Factor-β: A Multifunctional Regulator of Cancer Immunity.
Xue VW; Chung JY; Córdoba CAG; Cheung AH; Kang W; Lam EW; Leung KT; To KF; Lan HY; Tang PM
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33114183
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of immune microenvironment in ovarian cancer and its clinical significance: a retrospective study.
Gao Y; Chen L; Cai G; Xiong X; Wu Y; Ma D; Li SC; Gao Q
Oncoimmunology; 2020; 9(1):1760067. PubMed ID: 32391193
[TBL] [Abstract][Full Text] [Related]
33. Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
Markov AV; Odarenko KV; Sen'kova AV; Salomatina OV; Salakhutdinov NF; Zenkova MA
Molecules; 2020 Dec; 25(24):. PubMed ID: 33327637
[TBL] [Abstract][Full Text] [Related]
34. Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.
Cohen AD; Schaer DA; Liu C; Li Y; Hirschhorn-Cymmerman D; Kim SC; Diab A; Rizzuto G; Duan F; Perales MA; Merghoub T; Houghton AN; Wolchok JD
PLoS One; 2010 May; 5(5):e10436. PubMed ID: 20454651
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stem cells induce epithelial mesenchymal transition in melanoma by paracrine secretion of transforming growth factor-β.
Lv C; Dai H; Sun M; Zhao H; Wu K; Zhu J; Wang Y; Cao X; Xia Z; Xue C
Melanoma Res; 2017 Apr; 27(2):74-84. PubMed ID: 28079609
[TBL] [Abstract][Full Text] [Related]
36. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
Fuxe J; Karlsson MC
Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
[TBL] [Abstract][Full Text] [Related]
37. Rethinking the biology of metastatic melanoma: a holistic approach.
Vandyck HH; Hillen LM; Bosisio FM; van den Oord J; Zur Hausen A; Winnepenninckx V
Cancer Metastasis Rev; 2021 Jun; 40(2):603-624. PubMed ID: 33870460
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T Cells Induce Metastasis by Increasing Tgf-β and Enhancing the Epithelial–Mesenchymal Transition.
Oh E; Hong J; Yun CO
Cells; 2019 Nov; 8(11):. PubMed ID: 31690033
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
